FiND media coverage study for BSE 100 index companies showed a significant deterioration in the long-term news sentiment for Glenmark Pharmaceuticals, Vakrangee and fraud-hit Punjab National Bank (PNB).
These 3 companies have been receiving negative press coverage for quite some time. As a result, news sentiment 200-day moving average (DMA) for these 3 companies dipped to a 2-year low on Apr. 17, 2018.
[Image 1: Compare screen shows Sentiment 200-DMA] Read the rest of this entry »
Publically available data from Employees’ Provident Fund Organization (EPFO) is an important piece of information that can be consumed in risk assessment of corporate borrowers. In our view, deep-dive analytics on EPFO data can offer unique insights into the company’s functioning.
Through analysis of EPFO data, the banks can find out whether the companies in their loan portfolio are depositing employees’ provident fund (PF) on time or not; and whether there is any significant drop in the PF amount deposited by the company. At the same time, lenders can also identify companies which are downsizing the workforce.
FiND Credit Risk Early Warning System (EWS) consists of 25+ business rules that analyze the EPFO data for the companies every month. One of the key business rules is a delay in PF payment for a given month. In our view, a delay in PF payment may imply liquidity crunch for the company and hence it is a red flag for the banks.
Our hypothesis is that red flags related to PF payment can act as a leading indicator to the deterioration in the company’s financial performance. To test this hypothesis, we back-tested our engine on EPFO data for three months (Jan-17, Feb-17, and Mar-17) on the below-mentioned business rule:
Delay in monthly payment of PF by more than 10 days for more than 50 employees
From our EPFO data universe of 1,250+ companies, FiND EWS identified 35 companies who have delayed PF payment for all 3 months.
Then, we checked if there is any deterioration in the financial performance (captured by FiND Financial Risk score) for these companies post-March 2017 quarter.
We found that: 86% of companies (30/35) witnessed a deterioration in Financial Risk score in the subsequent quarters.
We highlight 10 such companies below:
[Image 1: Financial Risk Score for 10 Companies with PF red flags] Read the rest of this entry »
With a clear focus on reduction of the information arbitrage, Heckyl has developed a strategy based on FiND News Sentiment Indicator for identifying bullish/ bearish patterns for the benchmark index, sector as well as individual stocks.
FiND News Sentiment Indicator reflects the underlying sentiment of news coverage on the companies. The strategy based on this indicator signals the potential impact of the news sentiment on the value of underlying index or stock.
We have constructed our strategy by taking moving averages of FiND News Sentiment Indicator. Our system generates bullish/ bearish signals based on the crossover of shorter-term (20-days) and longer-term (60-days) moving averages of FiND News Sentiment Indicator.
Bullish: When short-term 20-DMA of FiND News Sentiment Indicator is above long-term 60-DMA, underlying index or stock tends to rise. It reflects an improvement in news sentiment in recent time when compared with the past 2-months.
Bearish: When short-term 20-DMA of FiND News Sentiment Indicator is below long-term 60-DMA, underlying index or stock tends to fall. It shows a deterioration in news sentiment in recent time when compared with the past 2-months.
For simplicity, we have defined sentiment intensity as a difference between 20-DMA and 60-DMA of FiND News Sentiment Indicator to showcase bullish and bearish phases.
When the value of sentiment intensity is above 0 (20-DMA > 60-DMA), then it is a sign of bullish trend ahead. On the other hand, fall in sentiment intensity value below 0 level (20-DMA < 60-DMA) reflects bearish trend ahead.
Our back-testing proved the application of FiND News Sentiment Strategy for trading/ investment in the market. FiND News Sentiment strategy has outperformed benchmark index, sector and stock returns across time periods.
Here, we are presenting the case study on the Nifty index, Nifty Pharma and Sun Pharma to showcase how bullish/bearish signals defined by News Sentiment Strategy can help trader/ investor for beating the index/ stock returns.
We analyzed over 1.56 lakh news items for 50 companies within the Nifty index for the past 3-years. Out the total, 1,19,162 news items were positive, while 37,175 news items were negative.
As can be seen in below chart (Image 1), bullish/bearish signals based on news sentiment strategy can give an early indication of upward/downward movement for the 50-share index.
[Image 1: Nifty Index and Bullish/ Bearish Period defined by Sentiment Intensity]
If a trader/ investor was to buy/sell Nifty as per the bullish/bearish signal and hold the position for the period till the signal reverses versus an investment in Nifty, the returns would be significantly higher.
[Image 2: Returns based on Sentiment Signal and Nifty Index performance] Read the rest of this entry »
Japan Airlines delivers industry-beating on-time performance; Air India consistently lags on punctuality
The on-time performance (OTP) is one of the most important performance indicators for airlines. It shows how frequently the airline has managed to operate flights within the declared scheduled time.
OTP is a measure of service quality/ punctuality. The higher OTP can help airlines to meet its customer expectations. At the same time, improvement in customer service can also boost airline’s profitability.
Over the past 24-months, OTP for Japan Airlines has consistently outperformed the industry average. On the other hand, OTP for state-run Air India has consistently remained below the industry average in the last 24-months except April 2017.
Heckyl’s alternative data platform FiND collects and organizes macro, micro, and financial data to provide unique insights into aviation sector.
To know more about FiND, email us at firstname.lastname@example.org
Mahindra & Mahindra (M&M), one of the leading automobile companies in India, witnessed a surge in news sentiment to a 5-year high helped by extremely positive media coverage in March 2018. A slew of new product launches by M&M over the past 1-month lifted news sentiment to the highest level in the past 5-years.
With buoyant media coverage, M&M has surpassed news sentiment of both Maruti Suzuki and Tata Motors in March 2018 for the first time in the last 16-months.
[Image 1: Compare screen highlights news sentiment 100-DMA]
A series of positive news items highlighting new product launches, alternative energy and partnerships during the past 1-month pushed M&M’s news sentiment 100-day moving average (DMA) to 84.11 on Apr. 7, 2018. Read the rest of this entry »
With a clear focus on reduction of the information arbitrage, Heckyl has built an alternative data platform FiND which collects and organizes macro, micro, and financial data to provide unique insights into pharmaceutical sector.
In our view, trading opportunities can be spotted in the stock market by discovery and analysis of vast amount of alternative data available on the web. One such data set is clinical trial study results for pharmaceutical companies.
Clinical trials are research studies that explore whether a drug or device is safe and effective for humans. The pharmaceutical products go through three phases of clinical trials followed by a regulatory approval process. After completing all three phases and the approval process, the company can start monetizing the drug or device.
The drugmakers report the progress of ongoing clinical trials for each phase from time to time. The result of late study trials (phase 2 and 3) can provide the best idea about a drug’s chances of approval. A favorable result of late study trials can be seen as positive by the market and vice-versa.
To help traders/ investors, we have introduced Calendar which tracks release dates for clinical trial, drug approval, patent expiry, operating stats and industry events.
We present a case study on Clearside Biomedical, Inc., a late-stage biopharmaceutical company developing drug therapies to treat back-of-the-eye diseases.
On Mar. 5, 2018, Clearside announced positive topline results from its pivotal Phase 3 clinical trial of suprachoroidal CLS-TA in patients with macular edema associated with non-infectious uveitis (Image 1).
(Image 1: News screen for Clearside) Read the rest of this entry »
Chanda Kochhar, managing director and chief executive officer, ICICI Bank, has been in the news lately after a controversy erupted over a conflict of interest in loan approved to the Videocon Group. There were reports in the media that Chanda Kochhar allegedly favored Videocon Group while granting Rs 3,250 crore loan.
However, ICICI Bank board termed the allegations as “malicious and unfounded” against its MD and CEO and reposed faith and confidence in Chanda Kochhar.
As the name of Chanda Kochhar cropped up in the Videocon loan controversy, news mentions for ICICI Bank chief surged towards the end of March.